Impact of vitamin D3 dietary supplement matrix on clinical response

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 8, 2014, Pages 2720-2728

  Traub, Michael L ^a   Finnell, John S ^b   Bhandiwad, Anup ^c   Oberg, Erica ^d   Suhaila, Lena ^e   Bradley, Ryan ^f  

^a Lokahi Health Center   (United States)

^b AOMA Graduate School of Integrative Medicine   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d Pacific Pearl Center for Health and Healing   (United States)

^e CANCER TREATMENT CENTERS OF AMERICA   (United States)

^f Bastyr University Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG DOSAGE FORM; FEMALE; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOSAGE FORMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84905860790     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3162     Document Type: Article

References (45)

1. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitaminDand risk of type 1 diabetes: a birth-cohort study. Lancet. 2001;358:1500-1503.
2. Pittas AG, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006; 29:650-656.
3. Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31-38.
4. Taskapan H, Wei M, Oreopoulos DG. 25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol. 2006;38:323-329.
5. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80:1678S-1688S.
6. Giovannucci E. The epidemiology of vitaminDand cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005;16:83-95.
7. Pilz S, Tomaschitz A, Obermayer-Pietsch B, Dobnig H, Pieber TR. Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res. 2009;29:3699-3704.
8. Giovannucci E. Epidemiology of vitamin D and colorectal cancer: casual or causal link? J Steroid Biochem Mol Biol. 2010;121:349-354.
9. Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17:2958-2969.
10. Autier P, Gandini S. VitaminDsupplementation and total mortality: a meta-analysis of randomized controlled trials. AMA Arch Intern Med. 2007;167:1730-1737.
11. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population.AMAArch Intern Med. 2008;168:1629-1637.
12. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J BIOMED INFORM. 2011;96:53-58.
13. Brannon PM, Yetley EA, Bailey RL, Picciano MF. Overview of the conference "VitaminDand Health in the 21st Century: an Update." Am J Clin Nutr. 2008;88:483S-490S.
14. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Ross AC, Taylor CL, Yaktine AL, and Del Valle HB, Eds. Washington (DC): National Academies Press (US); 2011.
15. Aloia JF, Patel M, Dimaano R, et al. Vitamin D intake to attain a desired serum 25-hydroxyvitaminDconcentration.AmJ Clin Nutr. 2008;87:1952-1958.
16. Talwar SA, Aloia JF, Pollack S, Yeh JK. Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr. 2007;86:1657-1662.
17. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson- Hughes B. Estimation of optimal serum concentrations of 25- hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18-28.
18. Vieth R, Ladak Y, Walfish PG. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J BIOMED INFORM. 2003;88:185-191.
19. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842-856.
20. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.AMA Arch Intern Med. 2008;168:1174-1180.
21. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77:204-210.
22. Chel V, Wijnhoven HA, Smit JH, Ooms M, Lips P. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int. 2008;19:663-671.
23. Pietras SM, Obayan BK, Cai MH, Holick MF. Vitamin D2 treatdoi ment for vitamin D deficiency and insufficiency for up to 6 years. AMA Arch Intern Med. 2009;169:1806-1808.
24. Saadi HF, Dawodu A, Afandi BO, Zayed R, Benedict S, Nagelkerke N. Efficacy of daily and monthly high-dose calciferol in vitamin D-deficient nulliparous and lactating women.AmJ Clin Nutr. 2007; 85:1565-1571.
25. Leventis P, Kiely PD. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol. 2009;38:149-153.
26. United States Pharmacopeial Convention. USP 35-NF 30: Dietary Supplements Compendium. Rockville, MD: United States Pharmacopeial Convention. 2012;1468-1510.
27. Miller RK, Celestino C, Giancaspro GI, Williams RL. FDA's dietary supplement CGMPs: standards without standardization. Food Drug Law J. 2008;63:929-942.
28. FDA, U.S. Code of Federal Regulations. In: Title 21, Volume 2, Part 101.9. D.o.H.a.H. Services, editor: 2012.
29. Ilahi M, Armas LA, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr. 2008;87:688-691.
30. Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan N. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Q J Med. 1986;59:569-577.
31. Taylor C, Lamparello B, Kruczek K, Anderson EJ, Hubbard J, Misra M. Validation of a food frequency questionnaire for determining calcium and vitamin D intake by adolescent girls with anorexia nervosa. J Am Diet Assoc. 2009;109:479-485, 485 e471-473.
32. Douglass JPJ. Bowes and Church's Food Values of Portions Commonly Used. Philadelphia: Lippincott Williams & Wilkins: 2004.
33. Nutrient-Data-Laboratory. USDA Nutrient Database for Standard Reference, Release 16. A.R.S. U.S. Department of Agriculture, editor: 2003.
34. Glanz K, Yaroch AL, Dancel M, et al. Measures of sun exposure and sun protection practices for behavioral and epidemiologic research. AMA Arch Derm Syphilol. 2008;144:217-222.
35. Ersfeld DL, Rao DS, Body JJ, et al. Analytical and clinical validation of the 25OHvitaminDassay for the LIAISON automated analyzer. J Clin Biochem Nutr. 2004;37:867-874.
36. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.
37. Zhao LJ, Zhou Y, Bu F, et al. Factors predicting vitaminDresponse variation in non-Hispanic white postmenopausal women. J BIOMED INFORM. 2012;97:2699-2705.
38. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72: 690-693.
39. Elnenaei MO, Chandra R, Mangion T, Moniz C. Genomic and metabolomic patterns segregate with responses to calcium and vitamin D supplementation. Br J Nutr. 2011;105:71-79.
40. Larcombe L, Mookherjee N, Slater J, et al. Vitamin D in a northern Canadian first nation population: dietary intake, serum concentrations and functional gene polymorphisms. PLoS One. 2012;7: e49872.
41. Muindi JR, Adjei AA, Wu ZR, et al. Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitaminDgenes. Horm Cancer. 2013;4:242-250.
42. Zhou Y, Zhao LJ, Xu X, et al. DNA methylation levels of CYP2R1 and CYP24A1 predict vitamin D response variation [published online October 12, 2013]. J Steroid Biochem Mol Biol. doi:10.1016/j.jsbmb.2013.10.004.
43. Phinney KW. Development of a standard reference material for vitamin D in serum. Am J Clin Nutr. 2008;88:511S-512S.
44. LeBlanc ES, Perrin N, Johnson JD Jr, Ballatore A, Hillier T. Overthe- counter and compounded vitamin d: Is potency what we expect? JAMA Intern Med. 2013:585-586.
45. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guidelineEvaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Biomed Inform. 2011;96:1911-1930.